Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus–Induced Acute Pneumonia

Influenza A virus (IAV) is the etiological agent of a highly contagious acute respiratory disease that causes epidemics and considerable mortality annually. Recently, we demonstrated, using an in vitro approach, that the pattern recognition Toll-like receptor (TLR)3 plays a key role in the immune response of lung epithelial cells to IAV. In view of these data and the fact that the functional role of TLR3 in vivo is still debated, we designed an investigation to better understand the role of TLR3 in the mechanisms of IAV pathogenesis and host immune response using an experimental murine model. The time-course of several dynamic parameters, including animal survival, respiratory suffering, viral clearance, leukocyte recruitment into the airspaces and secretion of critical inflammatory mediators, was compared in infected wild-type and TLR3 −/− mice. First, we found that the pulmonary expression of TLR3 is constitutive and markedly upregulated following influenza infection in control mice. Notably, when compared to wild-type mice, infected TLR3 −/− animals displayed significantly reduced inflammatory mediators, including RANTES (regulated upon activation, normal T cell expressed and secreted), interleukin-6, and interleukin-12p40/p70 as well as a lower number of CD8+ T lymphocytes in the bronchoalveolar airspace. More important, despite a higher viral production in the lungs, mice deficient in TLR3 had an unexpected survival advantage. Hence, to our knowledge, our findings show for the first time that TLR3-IAV interaction critically contributes to the debilitating effects of a detrimental host inflammatory response.

[1]  C. Loddenkemper,et al.  Self-Limitation of Th1-Mediated Inflammation by IFN-γ1 , 2006, The Journal of Immunology.

[2]  Shizuo Akira,et al.  Innate immune recognition of viral infection , 2006, Nature Immunology.

[3]  T. Doran,et al.  Immune responses to dsRNA: Implications for gene silencing technologies , 2005, Immunology and cell biology.

[4]  Martin F. Bachmann,et al.  Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection , 2005, Journal of Virology.

[5]  D. Woodland Faculty Opinions recommendation of Cutting edge: re-evaluating the in vivo cytokine responses of CD8+ T cells during primary and secondary viral infections. , 2005 .

[6]  I. Haga,et al.  The role of Toll-like receptors in the host response to viruses. , 2005, Molecular immunology.

[7]  R. Schumann,et al.  Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. , 2005, The Lancet. Infectious diseases.

[8]  S. Akira,et al.  Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus* , 2005, Journal of Biological Chemistry.

[9]  G. Sen,et al.  Transcriptional signaling by double-stranded RNA: role of TLR3. , 2005, Cytokine & growth factor reviews.

[10]  K. Hartshorn,et al.  Novel strategies for prevention and treatment of influenza , 2005, Expert opinion on therapeutic targets.

[11]  E. Kurt-Jones,et al.  Viruses and Toll-like receptors. , 2004, Microbes and infection.

[12]  E. Fikrig,et al.  Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis , 2004, Nature Medicine.

[13]  Takeshi Kurata,et al.  Defense mechanisms against influenza virus infection in the respiratory tract mucosa. , 2004, Japanese journal of infectious diseases.

[14]  P. Palese,et al.  Influenza: old and new threats , 2004, Nature Medicine.

[15]  F. Hayden Pandemic Influenza: Is an Antiviral Response Realistic? , 2004, The Pediatric infectious disease journal.

[16]  T. Toner,et al.  Comparative study of influenza virus replication in Vero and MDCK cell lines. , 2004, Journal of virological methods.

[17]  A. Williams,et al.  Ménage à trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lung , 2004, Clinical and experimental immunology.

[18]  K. Tyler,et al.  Does Toll-like receptor 3 play a biological role in virus infections? , 2004, Virology.

[19]  R. Flavell,et al.  Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Bronson,et al.  Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  L. Zhang,et al.  Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement , 2003, Journal of Clinical Virology.

[22]  C. Amici,et al.  NF‐κB and virus infection: who controls whom , 2003, The EMBO journal.

[23]  B. Vargaftig,et al.  Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production , 2003, Immunology.

[24]  A. Linde,et al.  Treatment and Prevention of Influenza: Swedish Recommendations , 2003, Scandinavian journal of infectious diseases.

[25]  Y. Guan,et al.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[26]  D. McGavern,et al.  T cells in the central nervous system: the delicate balance between viral clearance and disease. , 2002, The Journal of infectious diseases.

[27]  A. Abbas,et al.  Interferon γ Is Required for Activation-induced Death of T Lymphocytes , 2002, The Journal of experimental medicine.

[28]  G. Karupiah,et al.  FIELDS VIROLOGY, 4TH EDITION , 2002 .

[29]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[30]  F. Hayden,et al.  Symptom pathogenesis during acute influenza: Interleukin‐6 and Other cytokine responses , 2001, Journal of medical virology.

[31]  K. Melén,et al.  Survey Molecular Pathogenesis of Influenza a Virus Infection and Virus-induced Regulation of Cytokine Gene Expression , 1998 .

[32]  A. Cerwenka,et al.  Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. , 2001, The American journal of pathology.

[33]  M. Chignard,et al.  Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[34]  K. Reeth Cytokines in the pathogenesis of influenza. , 2000 .

[35]  K. Van Reeth Cytokines in the pathogenesis of influenza. , 2000, Veterinary microbiology.

[36]  Jeffrey S. Young,et al.  Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. , 1998, The Journal of clinical investigation.

[37]  D. Kioussis,et al.  Contribution of  Virus-specific CD8+ Cytotoxic T Cells to Virus Clearance or Pathologic Manifestations of Influenza Virus Infection in a T Cell Receptor Transgenic Mouse Model , 1998, The Journal of experimental medicine.

[38]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[39]  S. Kostense,et al.  Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice. , 1998, Antiviral research.

[40]  C. Bona,et al.  Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice , 1996, Journal of virology.

[41]  A. Alcamí,et al.  Receptors for gamma-interferon encoded by poxviruses: implications for the unknown origin of vaccinia virus. , 1996, Trends in microbiology.

[42]  F. Ennis,et al.  Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. , 1981, Journal of immunology.

[43]  R. Couch,et al.  Effects of Low- and High-Passage Influenza Virus Infection in Normal and Nude Mice , 1977, Infection and immunity.

[44]  F. Ennis,et al.  Influenza virus infection in nude mice. , 1976, The Journal of infectious diseases.

[45]  J. Hurd,et al.  Effect of cyclophosphamide on infections in mice caused by virulent and avirulent strains of influenza virus , 1975, Infection and immunity.

[46]  F. Suzuki,et al.  Effect of Antilymphocyte Serum on Influenza Virus Infection in Mice , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[47]  R. Kirschstein,et al.  Respiratory Diseases in Cyclophosphamide-Treated Mice II. Decreased Virulence of PR8 Influenza Virus , 1972, Infection and immunity.